Europa · Agencias y tiempo real · MarketScreener

Jefferies raises target price for Genmab, boosts view on oncology portfolio

Publicado por MarketScreener · Francia hace 13 h

Jefferies reiterates its Buy rating on Danish pharmaceutical company Genmab and raises its target price to DKK 3,200 from DKK 2,900. The research firm sees stronger potential for…

Leer el artículo completo en MarketScreener Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketscreener.com)

Jefferies raises target price for Genmab, boosts view on oncology portfolio

También te puede interesar

Kremlin aide describes coming week in Putin’s schedule as ‘extremely tight’

Fed expected to hold rates amid accelerating inflation ahead of November US midterms

AI gloom revives the specter of stagflation

FTSE 100 rises as falling oil prices boost risk appetite

Saudi Arabia to store oil in Singapore to bolster Asia supply security

Fed to hit pause on rate hikes, but maybe not for long

Jefferies raises target price for Genmab, boosts view on oncology portfolio

Compartir

También te puede interesar

Kremlin aide describes coming week in Putin’s schedule as ‘extremely tight’

Fed expected to hold rates amid accelerating inflation ahead of November US midterms

AI gloom revives the specter of stagflation

FTSE 100 rises as falling oil prices boost risk appetite

Saudi Arabia to store oil in Singapore to bolster Asia supply security

Fed to hit pause on rate hikes, but maybe not for long